Clover Health Investments Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名49/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價3.23。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Clover Health Investments Corp評分
相關信息
行業排名
49 / 78
全市場排名
211 / 4562
所屬行業
醫療服務供應商
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
3
分析師
持有
評級
3.233
目標均價
+26.30%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Clover Health Investments Corp亮點
亮點風險
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
公司代碼CLOV
公司Clover Health Investments Corp
CEOWai (Conrad)
網址https://www.cloverhealth.com/
常見問題
Clover Health Investments Corp(CLOV)的當前股價是多少?
Clover Health Investments Corp(CLOV)的當前股價是 2.530。
Clover Health Investments Corp 的股票代碼是什麼?
Clover Health Investments Corp的股票代碼是CLOV。
Clover Health Investments Corp股票的52週最高點是多少?
Clover Health Investments Corp股票的52週最高點是4.870。
Clover Health Investments Corp股票的52週最低點是多少?
Clover Health Investments Corp股票的52週最低點是2.120。
Clover Health Investments Corp的市值是多少?
Clover Health Investments Corp的市值是1.28B。
Clover Health Investments Corp的淨利潤是多少?
Clover Health Investments Corp的淨利潤為-43.01M。
現在Clover Health Investments Corp(CLOV)的股票是買入、持有還是賣出?
根據分析師評級,Clover Health Investments Corp(CLOV)的總體評級為持有,目標價格為3.233。
Clover Health Investments Corp(CLOV)股票的每股收益(EPS TTM)是多少
Clover Health Investments Corp(CLOV)股票的每股收益(EPS TTM)是-0.116。